Search Results - "Collins, Keagan P."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Kinetics of Cyclophosphamide Metabolism in Humans, Dogs, Cats, and Mice and Relationship to Cytotoxic Activity and Pharmacokinetics by Ramirez, Dominique A, Collins, Keagan P, Aradi, Allister E, Conger, Katherine A, Gustafson, Daniel L

    Published in Drug metabolism and disposition (01-03-2019)
    “…Cyclophosphamide (CP), a prodrug that is enzymatically converted to the cytotoxic 4-hydroxycyclophosphamide (4OHCP) by hepatic enzymes, is commonly used in…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Lysosomal Biogenesis and Implications for Hydroxychloroquine Disposition by Collins, Keagan P, Witta, Sandra, Coy, Jonathan W, Pang, Yi, Gustafson, Daniel L

    “…Lysosomes act as a cellular drug sink for weakly basic, lipophilic (lysosomotropic) xenobiotics, with many instances of lysosomal trapping associated with…”
    Get full text
    Journal Article
  5. 5

    Prospective clinical trial testing COXEN-based gene expression models of chemosensitivity in dogs with spontaneous osteosarcoma by Gustafson, Daniel L., Collins, Keagan P., Fowles, Jared S., Ehrhart, E. J., Weishaar, Kristen M., Das, Sunetra, Duval, Dawn L., Thamm, Douglas H.

    Published in Cancer chemotherapy and pharmacology (01-10-2021)
    “…Background This study is a prospective clinical trial in dogs with osteosarcoma testing a gene expression model (GEM) predicting the chemosensitivity of tumors…”
    Get full text
    Journal Article
  6. 6

    Vinca Alkaloid Pharmacokinetics in the Context of a Physiologically‐Based Murine Model by Collins, Keagan P., Mannheimer, Joshua D., Gustafson, Daniel L.

    Published in The FASEB journal (01-04-2018)
    “…Vinca alkaloids are a class of molecule clinically used as cytotoxic chemotherapeutics, and exert their activity through mitotic disruption by preventing the…”
    Get full text
    Journal Article
  7. 7

    Abstract 1503: A physiologically-based pharmacokinetic (PBPK) model of hydroxychloroquine by Collins, Keagan P., Jackson, Kristen M., Gustafson, Daniel L.

    Published in Cancer research (Chicago, Ill.) (01-07-2017)
    “…Hydroxychloroquine (HCQ) is a lysotropic autophagy inhibitor that is being used in over 45 clinical trials either alone or in combination with another…”
    Get full text
    Journal Article
  8. 8

    A Pharmacokinetic Investigation of Chloroquine Analogues in Cancer Autophagy Modulation by Collins, Keagan P

    Published 01-01-2020
    “…Hydroxychloroquine (HCQ) is currently being investigated for safety and efficacy as an autophagy inhibitor in Phase I/II cancer clinical trials. It is the only…”
    Get full text
    Dissertation